Arcticzymes Technologies ASA
Research Arcticzymes Technologies ASA (AZT.OL) on Bullrun: market cap NOK 1.00B, P/E 65.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAZT.OL
- ExchangeXOSL
- CountryNorway
- SectorHealthcare
- IndustryBiotechnology
- CurrencyNOK
- Market capNOK 1.00B
- P/E65.5
- Financial periodQ1 2026
- RevenueNOK 31.77M
- Net incomeNOK 585.00K
- Free cash flow-NOK 400.00K
- Gross margin93.2%
Valuation Snapshot
latest market cap is NOK 1.00B; P/E is 65.5.
Peer valuation comparison
Latest P/E is 65.5x versus a Healthcare sector median of 24.6x (166.3% above).
Latest P/E is 65.5x versus a Norway median of 14.52x (351.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | NOK 112.62M | NOK 10.34M | NOK 22.16M | 95.8% | 0.19 | NOK 185.98M | NOK 5.34M | NOK 338.32M |
| FY2024 | NOK 104.35M | NOK 8.47M | NOK 726.00K | n/a | 0.17 | n/a | n/a | NOK 324.25M |
| FY2023 | NOK 118.94M | NOK 19.43M | NOK 22.76M | n/a | 0.38 | NOK 180.89M | n/a | NOK 309.30M |
| FY2022 | NOK 136.97M | NOK 32.86M | NOK 53.58M | n/a | 0.65 | NOK 178.80M | n/a | NOK 284.74M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-10 | NOK 1.00B | 65.5 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 NOK.
About Arcticzymes Technologies ASA
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Arcticzymes Technologies ASA's market cap?
Arcticzymes Technologies ASA's market capitalization is NOK 1.00B.
What is Arcticzymes Technologies ASA's P/E ratio?
Arcticzymes Technologies ASA's price-to-earnings (P/E) ratio is 65.5.
What does Arcticzymes Technologies ASA do?
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA.